SCHEMBL21990137

SCHEMBL21990137

COC(=O)c1ccc2c(c1)N(Cc1ccccc1F)C(=O)C2(C)C

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
TSHR P16473 1/20 0.58
STING1 Q86WV6 1/20 0.51
CPT1A P50416 2/20 0.47
CPT1B Q92523 2/20 0.47
CPT2 P23786 1/20 0.47
MAPT P10636 3/20 0.44
POLB P06746 2/20 0.44
ALDH1A1 P00352 3/20 0.44
THRB P10828 2/20 0.43
TP53 P04637 2/20 0.42
GAA P10253 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21990074 0.88 STING1 (0.51) LMNAL3MBTL1TSHRSTING1CPT1A
SCHEMBL31411676 0.85 CPT1A (0.48) LMNAL3MBTL1TSHRSTING1CPT1A
SCHEMBL25943090 0.83 STING1 (0.61) LMNAL3MBTL1TSHRSTING1CPT1A
SCHEMBL25809782 0.83 STING1 (0.72) TSHRSTING1CPT1ACPT1BCPT2
SCHEMBL20594649 0.82 LMNA (0.51) LMNAL3MBTL1TSHRSTING1MAPT
SCHEMBL25942338 0.82 STING1 (0.55) LMNAL3MBTL1TSHRSTING1CPT1A
SCHEMBL21989994 0.82 STING1 (0.75) STING1CPT1ACPT1BCPT2MAPT
SCHEMBL29825029 0.82 STING1 (0.50) LMNAL3MBTL1STING1CPT1ACPT1B
SCHEMBL31411646 0.80 CPT1A (0.43) LMNAL3MBTL1TSHRSTING1CPT1A
SCHEMBL21990107 0.80 POLB (0.64) LMNAL3MBTL1TSHRSTING1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200172483-A1 HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LIMITED (GB) 2020-06-04 US disclosed
US-20200172483-A1 HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LIMITED (GB) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172483-A1 HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING STING1, IRF3, CGAS LMNA 4251/4885L3MBTL1 2965/4885TSHR 4194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.